Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1992 February; 55(2): 138–142.
PMCID: PMC488979

Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.


Decreased olfactory function is among the first signs of idiopathic Parkinson's disease (PD). Whether such dysfunction is present to the same degree on both sides of the nose, however, is unknown. Furthermore, whether the deficit results from or is influenced by anti-Parkinsonian medications has not been definitely established. Odour identification ability was evaluated on the left and right sides of the nose in 20 early-stage untreated PD patients, 20 early-stage treated PD patients, and 20 controls. In all cases, the PD related olfactory dysfunction was bilateral and no difference was observed between the test scores of patients taking or not taking drugs for PD. Although asymmetries of unsystematic direction were present in the test scores of some PD patients, similar asymmetries were observed in the controls and the asymmetries were not related to the side of the major motor dysfunction. As in earlier work, no relation was present between the olfactory test scores and the degree of tremor, rigidity, bradykinesia, or gait disturbance at the time of testing. These findings indicate that the olfactory dysfunction of early stage PD is robust, typically of the same general magnitude on both sides of the nose, and uninfluenced by anti-Parkinsonian medications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (975K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987 May;18(5):597–600. [PubMed]
  • Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits and Alzheimer's disease. Biol Psychiatry. 1986 Jan;21(1):116–118. [PubMed]
  • Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis. 1975 Oct;28(9):493–497. [PubMed]
  • Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand. 1974;50(5):539–547. [PubMed]
  • Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988 Aug;38(8):1237–1244. [PubMed]
  • Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol. 1989 Feb;25(2):166–171. [PubMed]
  • Serby M, Corwin J, Conrad P, Rotrosen J. Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Am J Psychiatry. 1985 Jun;142(6):781–782. [PubMed]
  • Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):88–89. [PMC free article] [PubMed]
  • Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology. 1983 Jul;33(7):943–946. [PubMed]
  • Doty RL, Perl DP, Steele JC, Chen KM, Pierce JD, Jr, Reyes P, Kurland LT. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology. 1991 May;41(5 Suppl 2):77–81. [PubMed]
  • Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):56–60. [PMC free article] [PubMed]
  • Hopper MW, Vogel FS. The limbic system in Alzheimer's disease. A neuropathologic investigation. Am J Pathol. 1976 Oct;85(1):1–20. [PubMed]
  • Ohm TG, Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol. 1987;73(4):365–369. [PubMed]
  • Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4531–4534. [PubMed]
  • Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature. 1989 Feb 23;337(6209):736–739. [PubMed]
  • HIRANO A, ZIMMERMAN HM. Alzheimer's neurofibrillary changes. A topographic study. Arch Neurol. 1962 Sep;7:227–242. [PubMed]
  • Eskenazi B, Cain WS, Novelly RA, Mattson R. Odor perception in temporal lobe epilepsy patients with and without temporal lobectomy. Neuropsychologia. 1986;24(4):553–562. [PubMed]
  • Bentin S, Silverberg R, Gordon HW. Asymmetrical cognitive deterioration in demented and Parkinson patients. Cortex. 1981 Dec;17(4):533–543. [PubMed]
  • Direnfeld LK, Albert ML, Volicer L, Langlais PJ, Marquis J, Kaplan E. Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings. Arch Neurol. 1984 Sep;41(9):935–941. [PubMed]
  • Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984 Mar;32(3):489–502. [PubMed]
  • Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984 Dec 21;226(4681):1441–1443. [PubMed]
  • Doty RL, Applebaum S, Zusho H, Settle RG. Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia. 1985;23(5):667–672. [PubMed]
  • Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA. 1990 Mar 2;263(9):1233–1236. [PubMed]
  • Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 1989 May;45(5):381–384. [PubMed]
  • Burdach KJ, Doty RL. The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiol Behav. 1987;41(4):353–356. [PubMed]
  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. [PubMed]
  • Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB., Jr Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991 May;117(5):519–528. [PubMed]
  • Harrison PJ. Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper. J R Soc Med. 1986 Jun;79(6):347–352. [PMC free article] [PubMed]
  • Roberts E. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiol Aging. 1986 Nov-Dec;7(6):561–567. [PubMed]
  • Barthold SW. Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta Neuropathol. 1988;76(5):502–506. [PubMed]
  • Boon AP, Potter AE. Extensive extrapontine and central pontine myelinolysis associated with correction of profound hyponatraemia. Neuropathol Appl Neurobiol. 1987 Jan-Feb;13(1):1–9. [PubMed]
  • Monath TP, Cropp CB, Harrison AK. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest. 1983 Apr;48(4):399–410. [PubMed]
  • Morales JA, Herzog S, Kompter C, Frese K, Rott R. Axonal transport of Borna disease virus along olfactory pathways in spontaneously and experimentally infected rats. Med Microbiol Immunol. 1988;177(2):51–68. [PubMed]
  • Tomlinson AH, Esiri MM. Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci. 1983 Aug-Sep;60(3):473–484. [PubMed]
  • Perl DP, Good PF. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet. 1987 May 2;1(8540):1028–1028. [PubMed]
  • Shipley MT. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull. 1985 Aug;15(2):129–142. [PubMed]
  • Baker H, Spencer RF. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res. 1986;63(3):461–473. [PubMed]
  • Cancalon P, Beidler LM. Distribution along the axon and into various subcellular fractions of molecules labeled with (3H)leucine and rapidly transported in the garfish olfactory nerve. Brain Res. 1975 May 23;89(2):225–244. [PubMed]
  • Steventon GB, Heafield MT, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology. 1989 Jul;39(7):883–887. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group